Alterations in the intestinal microbiota of patients with severe and active Graves’ orbitopathy: a cross-sectional study-Reference-Cited by-同舟云学术

Alterations in the intestinal microbiota of patients with severe and active Graves’ orbitopathy: a cross-sectional study

Published:2019-01-23 Issue:8 Volume:42 Page:967-978
ISSN:1720-8386
Container-title:Journal of Endocrinological Investigation
language:en
Short-container-title:J Endocrinol Invest

Author:

Shi T.-T.,Xin Z.^ORCID,Hua L.,Zhao R.-X.,Yang Y.-L.,Wang H.,Zhang S.,Liu W.,Xie R.-R.

Funder

The Beijing Municipal Hospital Research and Development Program

The Expert Promotion Program of Beijing Health Systems

The Foundation of Beijing Tongren Hospital

Publisher

Springer Science and Business Media LLC

Subject

Endocrinology,Endocrinology, Diabetes and Metabolism

Link

http://link.springer.com/content/pdf/10.1007/s40618-019-1010-9.pdf

Reference32 articles.

1. Kahaly GJ, Bartalena L, Hegedus L, Leenhardt L, Poppe K, Pearce SH (2018) 2018 European Thyroid Association Guideline for the Management of Graves’ Hyperthyroidism. Eur Thyroid J 7:167–186

2. Drui D, Du Pasquier Fediaevski L, Vignal Clermont C, Daumerie C (2018) Graves’ orbitopathy: diagnosis and treatment. Ann Endocrinol (Paris) 79:656–664

3. Bartalena L, Baldeschi L, Boboridis K, Eckstein A, Kahaly GJ, Marcocci C, Perros P, Salvi M, Wiersinga WM, European Group on Graves’ Orbitopathy (2016) The 2016 European Thyroid Association/European Group on Graves’ Orbitopathy guidelines for the Management of Graves’ Orbitopathy. Eur Thyroid J 5:9–26

4. Piantanida E, Tanda ML, Lai A, Sassi L, Bartalena L (2013) Prevalence and natural history of Graves’ orbitopathy in the XXI century. J Endocrinol Invest 36:444–449

5. Perros P, Hegedus L, Bartalena L, Marcocci C, Kahaly GJ, Baldeschi L, Salvi M, Lazarus JH, Eckstein A, Pitz S, Boboridis K, Anagnostis P, Ayvaz G, Boschi A, Brix TH, Curro N, Konuk O, Marino M, Mitchell AL, Stankovic B, Toruner FB, von Arx G, Zarkovic M, Wiersinga WM (2017) Graves’ orbitopathy as a rare disease in Europe: a European Group on Graves’ Orbitopathy (EUGOGO) position statement. Orphanet J Rare Dis 12:72

Cited by 47 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Significance of Gut Microbiota on Graves’ Disease;International Journal of General Medicine;2024-09

2. Exploring gut microbiota and metabolite alterations in patients with thyroid-associated ophthalmopathy using high-throughput sequencing and untargeted metabolomics;Frontiers in Endocrinology;2024-07-29

3. Graves disease: latest understanding of pathogenesis and treatment options;Nature Reviews Endocrinology;2024-07-22

4. The relationship between the gut microbiota and thyroid disorders;Nature Reviews Endocrinology;2024-06-21

5. Vitamin D: An Essential Nutrient in the Dual Relationship between Autoimmune Thyroid Diseases and Celiac Disease—A Comprehensive Review;Nutrients;2024-06-04